The new platform helped UC San Diego scientists synthesize 32 potential multi-target cancer drugs.
Scientists at UC San Diego have developed a machine learning algorithm to simulate the time-consuming chemistry involved in the earliest phases of drug discovery, which could significantly streamline the process and open doors for never-before-seen treatments. Identifying candidate drugs for further optimization typically involves thousands of individual experiments, but the new artificial intelligence (AI) platform could potentially give the same results in a fraction of the time.
The researchers used the new tool, described today (May 6) in Nature Communications, to synthesize 32 new drug candidates for cancer.
The Shift Toward AI in Pharmaceuticals
The technology is part of a new but growing trend in pharmaceutical science of using AI to improve drug discovery and development.
"A few years ago, AI was a dirty word in the pharmaceutical industry, but now the trend is definitely the opposite, with biotech startups finding it difficult to raise funds without addressing AI in their business plan," said senior author Trey Ideker, professor in the Department of Medicine at UC San Diego School of Medicine and adjunct professor of bioengineering and computer science at the UC San Diego Jacobs School of Engineering. "AI-guided drug discovery has become a very active area in industry, but unlike the methods being developed in companies, we're making our technology open source and accessible to anybody who wants to use it."
Advantages of Multi-Target Drug Discovery
The new platform, called POLYGON, is unique among AI tools for drug discovery in that it can identify molecules with multiple targets, while existing drug discovery protocols currently prioritize single target therapies. Multi-target drugs are of major interest to doctors and scientists because of their potential to deliver the same benefits as combination therapy, in which several different drugs are used together to treat cancer, but with fewer side effects.
"It takes many years and millions of dollars to find and develop a new drug, especially if we're talking about one with multiple targets." said Ideker. "The rare few multi-target drugs we do have were discovered largely by chance, but this new technology could help take chance out of the equation and kickstart a new generation of precision medicine."
How POLYGON Works
The researchers trained POLYGON on a database of over a million known bioactive molecules containing detailed information about their chemical properties and known interactions with protein targets. By learning from patterns found in the database, POLYGON is able to generate original chemical formulas for new candidate drugs that are likely to have certain properties, such as the ability to inhibit specific proteins.
"Just like AI is now very good at generating original drawings and pictures, such as creating pictures of human faces based off desired properties like age or sex, POLYGON is able to generate original molecular compounds based off of desired chemical properties," said Ideker. "In this case, instead of telling the AI how old we want our face to look, we're telling it how we want our future drug to interact with disease proteins."
Study co-author Katherine Licon, photographed here at the bench, is lab manager for the Ideker Lab at UC San Diego, which combines computational and traditional wet-lab techniques to answer fundamental questions about disease biology and discover new ways to enhance precision medicine. Credit: Erik Jepsen/UC San Diego
Testing and Results
To put POLYGON to the test, the researchers used it to generate hundreds of candidate drugs that target various pairs of cancer-related proteins. Of these, the researchers synthesized 32 molecules that had the strongest predicted interactions with the MEK1 and mTOR proteins, a pair of cellular signaling proteins that are a promising target for cancer combination therapy. These two proteins are what scientists call synthetically lethal, which means that inhibiting both together is enough to kill cancer cells even if inhibiting one alone is not.
The researchers found that the drugs they synthesized had significant activity against MEK1 and mTOR, but had few off-target reactions with other proteins. This suggests that one or more of the drugs identified by POLYGON could be able to target both proteins as a cancer treatment, providing a list of choices for fine-tuning by human chemists.
"Once you have the candidate drugs, you still need to do all the other chemistry it takes to refine those options into a single, effective treatment," said Ideker. "We can't and shouldn't try to eliminate human expertise from the drug discovery pipeline, but what we can do is shorten a few steps of the process."
Future of AI in Drug Discovery
Despite this caution, the researchers are optimistic that the possibilities of AI for drug discovery are only just being explored.
"Seeing how this concept plays out over the next decade, both in academia and in the private sector, is going to be very exciting," said Ideker. "The possibilities are virtually endless."
Reference: 6 May 2024,
Co-authors of the study include: Brenton Munson, Michael Chen, Audrey Bogosian, Jason Kreisberg, Katherine Licon, Abagyan Ruben and Brent Kuenzi, all at UC San Diego.
This study was funded, in part, by the National Institutes of Health (Grants CA274502, GM103504, ES014811, CA243885, CA212456).
News
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
Scientists Melt Cancer’s Hidden “Power Hubs” and Stop Tumor Growth
Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they were able to halt cancer [...]
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
